Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
7.79
+0.28 (3.73%)
May 8, 2025, 4:00 PM EDT - Market closed
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $425.95 million as of May 8, 2025. Its market cap has increased by 114.59% in one year.
Market Cap
425.95M
Enterprise Value
416.75M
1-Year Change
114.59%
Ranking
Category
Stock Price
$7.79
Market Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $425.95M, an increase of 209.11%. That is a compound annual growth rate of 11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 406.40M | -8.72% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.45B |
| Johnson & Johnson | 372.94B |
| UnitedHealth Group | 368.47B |
| AbbVie | 346.84B |
| Novo Nordisk | 309.41B |
| Abbott Laboratories | 230.70B |
| AstraZeneca | 221.69B |
| Novartis AG | 221.37B |